Much effort has been devoted to improving treatment efficiency for osteosarcoma(OS).However,most current approaches result in poor therapeutic responses,thus indicating the need for the development of other therapeuti...Much effort has been devoted to improving treatment efficiency for osteosarcoma(OS).However,most current approaches result in poor therapeutic responses,thus indicating the need for the development of other therapeutic options.This study developed a multifunctional nanoparticle,PDA-MOF-E-M,an aggregation of OS targeting,programmed death targeting,and near-infrared(NIR)-aided targeting.At the same time,a multifunctional nanoparticle that utilises Fe-MOFs to create a cellular iron-rich environment and erastin as a ferroptosis inducer while ensuring targeted delivery to OS cells through cell membrane encapsulation is presented.The combination of PDA-MOF-E-M and PTT increased intracellular ROS and LPO levels and induced ferroptosis-related protein expression.A PDA-based PTT combined with erastin showed significant synergistic therapeutic improvement in the anti-tumour efficiency of the nanoparticle in vitro and vivo.The multifunctional nanoparticle efficiently prevents the osteoclasia progression of OS xenograft bone tumors in vivo.Finally,this study provides guidance and a point of reference for clinical approaches to treating OS.展开更多
基金supported by the National Natural Science Foundation of China(Grant No.82373297).
文摘Much effort has been devoted to improving treatment efficiency for osteosarcoma(OS).However,most current approaches result in poor therapeutic responses,thus indicating the need for the development of other therapeutic options.This study developed a multifunctional nanoparticle,PDA-MOF-E-M,an aggregation of OS targeting,programmed death targeting,and near-infrared(NIR)-aided targeting.At the same time,a multifunctional nanoparticle that utilises Fe-MOFs to create a cellular iron-rich environment and erastin as a ferroptosis inducer while ensuring targeted delivery to OS cells through cell membrane encapsulation is presented.The combination of PDA-MOF-E-M and PTT increased intracellular ROS and LPO levels and induced ferroptosis-related protein expression.A PDA-based PTT combined with erastin showed significant synergistic therapeutic improvement in the anti-tumour efficiency of the nanoparticle in vitro and vivo.The multifunctional nanoparticle efficiently prevents the osteoclasia progression of OS xenograft bone tumors in vivo.Finally,this study provides guidance and a point of reference for clinical approaches to treating OS.
